Pancreatic Cancer Research

ResearcherPurdue University West LafayetteActive in the last 2 years

Luis Solorio

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0135-8728; OpenAlex author ID A5054791772; NIH RePORTER profile ID 11315984. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
3
Labs led
1
Collaborators
6
Papers, trials and grants by year

2016: 1 grant · 2017: none · 2018: none · 2019: 1 grant · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 grant

Papers 1

  1. KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development. Co-author DOI 10.1038/s41388-024-03196-w↗

Grants 3

  1. Stromal targeting to improve the efficacy of systemically administered drugs for pancreatic ductal adenocarcinomas R01CA283394↗
  2. Engineering the Cancer Microenvironment R00CA198929↗
  3. Engineering the Cancer Microenvironment K99CA198929↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Garima Baral · 1 shared paper, 2024 · strength 0.17
  2. Isabel A. English · 1 shared paper, 2024 · strength 0.17
  3. Samantha L. Tinsley · 1 shared paper, 2024 · strength 0.17
  4. Marina Pasca di Magliano · 1 shared paper, 2024 · strength 0.17
  5. Rosalie C. Sears · 1 shared paper, 2024 · strength 0.17
  6. Brittany L. Allen-Petersen · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.